KIT and acute myeloid leukemia: Then we assessed c-KIT suppression by dasatinib and radotinib in c-KIT-positive AML cells which are associated with clathrin-coated vesicles using DY, a potent inhibitor of dynamin GTPase, which is crucial for clathrin-coated vesicle formation30.